A Patient's Wait: How Fee Schedule Cuts Delay Critical Cardiac Care

When David felt a crushing tightness in his chest while doing the dishes one evening in his Brisbane home, he thought it was just indigestion from a heavy barbie lunch. Within hours he would be in a private hospital on the Gold Coast, watching a cardiologist explain that one of his coronary arteries was almost completely blocked and he needed a stent fitted without delay. The catch was that the procedure could not be scheduled for another three weeks because the practice had recently lost staff after a cut to Medicare rebates for interventional cardiology made it financially unviable to keep the catheterisation lab running at full capacity.

Australia's healthcare system is held up as a model of universal access, yet the way specialists are paid through the Medicare Benefits Schedule quietly shapes who gets treated, where, and how quickly. When those rebates shrink, the consequences land not in Canberra policy briefings but in waiting rooms from Parramatta to Penrith, from Footscray to Fremantle. Cardiac care is particularly exposed because timely intervention is often the difference between a full recovery and permanent heart muscle damage.

The Day Everything Changed

David, a 58-year-old truck driver from Logan, had ignored the warning signs for months. Shortness of breath climbing the stairs at work, a dull ache in his left arm he had to put down to a pulled muscle, and breathlessness he just called being "a bit knackered" after too many long hauls along the Hume. His wife finally drove him to the local emergency department one arvo after he started sweating through his work shirt while unloading crates at a warehouse in Yatala.

The triage team picked up the abnormal ECG within minutes. Blood tests confirmed elevated troponin levels. The on-call cardiologist booked him in for an angiogram with a view to stenting the culprit lesion, but the hospital's only remaining interventional slot for the following week had already been allocated to a regional patient flown in from Cairns. Because the unit operated on a roster that depended on a specific number of funded sessions each month, the next available window was over three weeks away. The cardiology team started him on aggressive medical therapy and sent him home with strict instructions to avoid exertion, a situation that left him, as he put it, "sitting around the house like a stunned mullet, worried the whole thing would go off again before I got back."

How Medicare Rebates Shape Cardiology Access

In Australia, the Medicare Benefits Schedule sets the rebate the government pays for each clinical service, including diagnostic angiography and percutaneous coronary intervention with stent insertion. Specialists may charge above the rebate, but the gap between the rebate and the actual cost of running a high-quality catheterisation laboratory has widened sharply over the past decade. Equipment, single-use consumables, contrast media, and the salaries of specialised nursing and radiography staff have all climbed far faster than the indexation applied to MBS items.

When rebates are frozen or cut, practices face a difficult choice. They can absorb the loss, reduce the number of lists they run, or stop offering the service altogether. Some bulk-billing cardiology clinics in outer metropolitan areas of Sydney and Melbourne have already closed their procedural arms. Regional centres in the Hunter Valley and the Illawarra have reported waiting lists stretching past two months for elective stent procedures, and even semi-urgent cases are being pushed back. The Campaign for Patient Access has been vocal about what happens when these funding decisions undermine the ability of cardiologists to deliver timely care, framing it as a fight to protect access to cardiology for everyone who needs it.

The difference between adequate and inadequate reimbursement is not abstract. It shows up in the number of sessions a hospital can staff, the speed at which a patient moves from emergency to intervention, and the long-term damage to heart muscle that could have been avoided. The figures below set out how typical Australian procedural cardiology rebates compare with the real costs of delivering those services.

Service	MBS Rebate (approximate, AUD)	Real Cost to Provider	Gap
Diagnostic coronary angiogram	350	1,400	-1,050
Single vessel PCI with drug-eluting stent	1,200	4,800	-3,600
Complex multivessel PCI	1,800	7,200	-5,400
Fractional flow reserve assessment	180	600	-420
Follow-up specialist consultation	75	250	-175

When the gap is consistently negative, the only way a practice can keep operating is to cross-subsidise from private fees, reduce volume, or close. None of those options helps a patient like David, whose life depends on the public system being available at short notice.

The Real Cost of Waiting

Cardiologists often refer to the phrase "time is muscle" because heart tissue that is starved of blood begins to die within minutes and cannot regenerate. Delaying a stent procedure by even a few weeks can mean the difference between a heart that pumps effectively for decades and one that fails within a few years. For David, the three-week wait brought a second admission to hospital with unstable angina, a longer inpatient stay, and an eventual procedure performed under higher-risk emergency conditions.

Patients in similar situations describe the same pattern. They cancel work, lean on family members for transport, and live with the constant fear that the next twinge in their chest could be the one that does not resolve. Mental health suffers. Spouses take unpaid leave to drive partners to repeated appointments. Some patients in rural New South Wales and country Victoria simply decide the trip is too much and present too late, when the damage to their heart is already extensive.

The downstream cost is borne by the hospital system as well. Longer inpatient stays, more complex emergency interventions, and higher rates of heart failure admission all flow from a single delayed stent. What might have been a day procedure becomes a week-long hospitalisation, and what might have been a quick recovery becomes a lifetime of medication and lifestyle restriction.

Voices from the Waiting Room

Stories like David's are not isolated. Cardiologists, practice managers, and patient advocacy groups have begun collecting testimonies to push back against further rebate reductions. Several themes appear again and again across submissions sent to professional bodies like the Cardiac Society of Australia and New Zealand.

Common themes emerging from patient and clinician submissions:

• Practices in western Sydney and south-east Queensland have closed their public lists after rebates failed to keep pace with costs.
• Regional patients from towns like Ballarat, Mackay, and Launceston face additional travel and accommodation barriers when local services are withdrawn.
• Specialists report younger patients presenting with advanced disease because preventive cardiology has been scaled back.
• Hospital emergency departments are bearing the cost of deferred care through higher admission numbers and longer stays.
• Private health insurers are reluctant to raise rebates in line with clinical complexity, leaving many policyholders facing large gaps.
• Patients with private cover often still wait because their cardiologist's public list is full and their private sessions are limited.

These stories form the evidence base that advocacy organisations rely on when they brief MPs, write to ministers, and engage with the broader health policy debate. Beyond cardiac care, communities have watched funding decisions reshape access to many essential supports, including education and training pathways that determine where future specialists will practise. A useful example of how policy advocacy can rally community voices comes from a French grassroots push to reopen teacher training colleges in every department, a campaign that reminds patients how powerful local organising can be when essential services are threatened.

Building a Fairer Funding Model

Reversing the trend will require sustained engagement from clinicians, patients, and policymakers. Practically, that means fairer indexation of MBS items for procedural cardiology, ring-fenced funding for regional catheterisation labs, and a national framework that recognises the true cost of delivering high-quality cardiac care. It also means amplifying patient stories so that decision makers in Canberra and across state health ministries hear directly from those whose lives are shaped by these funding decisions.

Practical steps that would make a tangible difference:

• Tie MBS indexation for procedural cardiology to a recognised measure of cost growth, such as the health-specific CPI.
• Fund a network of regional catheterisation laboratories with guaranteed session volumes in places like Townsville, Wagga Wagga, and Burnie.
• Expand training positions for interventional cardiologists in outer metropolitan and regional centres.
• Require private health insurers to update their schedules in line with revised MBS items within twelve months of any change.
• Create a national reporting framework for delayed cardiac procedures, similar to existing elective surgery waiting list reporting.
• Establish a patient advisory council with direct input into Medicare item reviews for high acuity specialties.

Fair reimbursement is not a boutique concern. It is the foundation of safe, timely cardiac care across Australia, and the policy choices made in the next budget cycle will determine whether stories like David's become rarer or more common. Cardiologists, practice managers, and patient groups are ready to work with government on practical solutions, but they need the data, the funding, and the political will to make it happen.

If David's experience resonates, the most powerful step anyone can take is to share it. Add your voice to the patient story archive, contact your federal MP, and support the work of organisations campaigning to keep cardiology services available wherever they are needed. No patient should have to spend three weeks sitting at home wondering if their next breath will be their last, and no cardiologist should have to choose between staying open and keeping the lights on. The system can be fixed, but only if the people affected by it make their voices heard.